Transocean Ltd. current report, 30 September 2026

Transocean Ltd. 8-K Summary

Business context and reporting period

Filed September 30, 2026, to report a transaction update. This is not a quarterly or annual financial-results filing.

Proposed Valaris acquisition

Transocean and Valaris entered into a Business Combination Agreement on February 9, 2026. Under its terms, Transocean would acquire all outstanding Valaris common shares in exchange for 15.235 Transocean shares per Valaris share.

On September 30, the companies were notified that the U.S. Department of Justice had closed its antitrust investigation. The Hart-Scott-Rodino waiting period expired. The companies anticipated closing in the fourth quarter of 2026, subject to satisfaction or waiver of the agreement’s remaining conditions.

Financial metrics and changes

The filing does not report revenue, profit, cash flow, margins, debt, liquidity, or other operating financial results. It provides no financial-period comparison or transaction valuation.

Outlook, risks, and contingencies

Completion and timing are not assured. The filing identifies risks including remaining closing conditions and approvals, litigation, disruption to operations and business relationships, potential contract changes, integration costs, failure to achieve or delay in realizing synergies, and inability to deleverage as expected. It also notes broader market, operational, regulatory, geopolitical, and offshore-drilling risks.

A joint preliminary proxy statement was filed with the SEC on May 19, 2026; a definitive proxy statement is expected to be distributed when available. The filing urges shareholders to review transaction documents when filed.

Important facts to verify

  • Whether remaining closing conditions and shareholder approvals are satisfied or waived.
  • Whether the transaction closes on the anticipated fourth-quarter 2026 timetable.
  • The final terms, including the 15.235-share exchange ratio, and any material updates in definitive transaction documents.
  • Expected transaction benefits, integration costs, and deleveraging assumptions in subsequent filings.